Recent Finacing
Recent Raise
ArrePath uses a proprietary AI/ML platform and deep phenotypic imaging to discover and optimize anti-infective small molecules with novel mechanisms, advancing dual-delivery leads targeting multidrug-resistant Gram-negative pathogens.
